01—Abstract
Summary
Summary of the 10-K filed February 26, 2010. Cited figures are marked; the original filing is the authoritative source.
Aflac Incorporated's 2009 10-K filing reveals a robust financial performance, largely driven by its significant operations in Japan, which contributed approximately 73%a of total revenues and 85% of total assets.
Despite challenging global economic conditions, the company demonstrated resilience with total revenues increasing to $18.3 billionb and net earnings reaching $1.5 billion. However, the company incurred significant net realized investment losses of $1.2 billion in 2009, primarily due to other-than-temporary impairments totaling $1.4 billion. These impairments were largely concentrated in perpetual securities, corporate bonds, and collateralized debt obligations.
Management highlighted a strategic focus on strengthening its capital position through debt issuance and suspending stock repurchases. The company also continues to diversify its product offerings in both its U.S. and Japan segments, with particular emphasis on enhanced medical and life insurance products in Japan and streamlined accident and cancer plans in the U.S. The report also notes the ongoing impact of healthcare reform discussions in the U.S. and the company's strong solvency ratios in Japan.
02—Key points
Key Highlights
- Aflac Japan remains the dominant segment, accounting for approximately 73% of total revenues and 85% of total assets, underscoring the company's significant exposure to the Japanese market.
- Net earnings for 2009 were $1.5 billion, a notable increase from $1.3 billion in 2008, driven partly by a stronger yen.
- The company recorded substantial net realized investment losses of $1.2 billion in 2009, primarily due to other-than-temporary impairments totaling $1.4 billion, impacting the profitability of the investment portfolio.
- The U.S. segment experienced a sales decline of 6.4% in total new annualized premium sales in 2009 due to weak economic conditions, though management expressed optimism about future recovery.
- Aflac Japan saw a 24.4% increase in pretax operating earnings, benefiting from a growing demand for medical insurance products and the expansion of its bank distribution channel.
- The company acquired Continental American Insurance Group, Inc. (CAIC) in Q4 2009 for $100 million, strengthening its platform for voluntary group insurance products distributed by insurance brokers in the U.S.
- Aflac maintained strong solvency positions in both Japan (885.5% solvency margin ratio) and the U.S. (479% company action level RBC ratio), exceeding regulatory minimums.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2009filed February 26, 2010Financial Statements
FY2009 against FY2008
| Line item | FY2009FY2008 | Change |
|---|---|---|
| Revenue | $18.25B$16.55B | +10.3% |
| SG&A Expenses | $1.98B$1.74B | +13.4% |
| Operating Income | $3.44B— | — |
| Interest Expense | $72.00M$29.00M | +148.3% |
| Net Income | $1.50B$1.25B | +19.4% |
| EPS (Basic) | $1.60$1.32 | +21.1% |
| EPS (Diluted) | $1.59$1.31 | +21.8% |
| Shares Outstanding (Basic) | 933.10M946.81M | −1.4% |
| Shares Outstanding (Diluted) | 938.13M957.63M | −2.0% |
05—Questions
Frequently Asked Questions
What was Aflac's financial performance in 2009, considering the global economic downturn?
In 2009, Aflac demonstrated resilience despite challenging global economic conditions. Total revenues increased to $18.3 billion, up from $16.6 billion in 2008. Net earnings rose to $1.5 billion, or $3.19 per diluted share, compared to $1.3 billion, or $2.62 per diluted share, in the prior year. This performance was partially supported by a stronger Japanese yen.
What was the impact of investments on Aflac's 2009 results?
Aflac experienced significant net realized investment losses of $1.2 billion in 2009. This was primarily driven by other-than-temporary impairments totaling $1.4 billion, which were concentrated in perpetual securities, corporate bonds, and collateralized debt obligations, reflecting the difficult capital markets environment.
How did the U.S. and Japan segments perform in 2009?
Aflac Japan continued to be the primary growth engine, with pretax operating earnings increasing by 24.4% to $2.8 billion, driven by strong medical insurance sales and an expanding bank distribution channel. In contrast, the U.S. segment faced headwinds from the weak economy, resulting in a 6.4% decline in new annualized premium sales for accident/disability and cancer insurance products. However, the acquisition of CAIC was a strategic move to bolster the U.S. group insurance offerings.
What is Aflac's approach to capital management and regulatory compliance?
Aflac maintained a strong capital position throughout 2009. It raised capital through debt offerings and suspended its stock repurchase program to bolster its financial strength. The company reported robust solvency margins in both its Japanese (885.5%) and U.S. (479% company action level RBC ratio) operations, comfortably exceeding regulatory requirements. Regulatory compliance and adherence to solvency standards remain key priorities.
06—Continue